Showing results (51-60 of 5,803) with videos related to
Sort By:
Pageof 581
Journal of Human Hypertension|February 19, 2010
Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertensionS G Chrysant, J Lee, M Melino, et al.Angiology|December 1, 1976
Effects of diuretics on lipid metabolism in patients with essential hypertensionS G Chrysant, G K Neller, B Dillard, et al.Clinical Cardiology|September 1, 1985
Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitorS G Chrysant, I S Bal, B Johnson, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.Angiology|April 1, 1978
Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive ratsS G Chrysant, G M Walsh, E D Frohlich, et al.Chest|September 1, 1989
Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspectsS G Chrysant, C Chrysant, I S Bal, et al.Clinical Pharmacology and Therapeutics|June 1, 1983
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalaprilS G Chrysant, R D Brown, D C Kem, et al.The American Journal of Cardiology|June 1, 1978
Abrupt cessation of clonidine administration: a prospective studyT L Whitsett, S G Chrysant, B L Dillard, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertensionS Oparil, D Williams, S G Chrysant, et al.Archives of Internal Medicine|January 1, 1978
Ticrynafen: a novel uricosuric antihypertensive natriuretic agentJ G de Carvalho, F G Dunn, S G Chrysant, et al.Pageof 581